Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) : 2020 Guideline on Diagnosis and Management of Babesiosis
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.
| Errataetall: |
ErratumIn: Clin Infect Dis. 2021 Jul 1;73(1):172-173. - PMID 33960362 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 72(2021), 2 vom: 27. Jan., Seite e49-e64 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krause, Peter J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.04.2021 Date Revised 07.05.2021 published: Print ErratumIn: Clin Infect Dis. 2021 Jul 1;73(1):172-173. - PMID 33960362 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa1216 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318190338 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318190338 | ||
| 003 | DE-627 | ||
| 005 | 20231225164833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa1216 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318190338 | ||
| 035 | |a (NLM)33252652 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krause, Peter J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) |b 2020 Guideline on Diagnosis and Management of Babesiosis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2021 | ||
| 500 | |a Date Revised 07.05.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: Clin Infect Dis. 2021 Jul 1;73(1):172-173. - PMID 33960362 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
| 520 | |a The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Auwaerter, Paul G |e verfasserin |4 aut | |
| 700 | 1 | |a Bannuru, Raveendhara R |e verfasserin |4 aut | |
| 700 | 1 | |a Branda, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Falck-Ytter, Yngve T |e verfasserin |4 aut | |
| 700 | 1 | |a Lantos, Paul M |e verfasserin |4 aut | |
| 700 | 1 | |a Lavergne, Valéry |e verfasserin |4 aut | |
| 700 | 1 | |a Meissner, H Cody |e verfasserin |4 aut | |
| 700 | 1 | |a Osani, Mikala C |e verfasserin |4 aut | |
| 700 | 1 | |a Rips, Jane Glazer |e verfasserin |4 aut | |
| 700 | 1 | |a Sood, Sunil K |e verfasserin |4 aut | |
| 700 | 1 | |a Vannier, Edouard |e verfasserin |4 aut | |
| 700 | 1 | |a Vaysbrot, Elizaveta E |e verfasserin |4 aut | |
| 700 | 1 | |a Wormser, Gary P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 72(2021), 2 vom: 27. Jan., Seite e49-e64 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2021 |g number:2 |g day:27 |g month:01 |g pages:e49-e64 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa1216 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2021 |e 2 |b 27 |c 01 |h e49-e64 | ||